Convulsant×Panorama Data Insights Ltd. - メーカー・企業と製品の一覧

[Market Report] Global Market for Gabapentin

The global market for Gabapentin is thriving, expected to reach 292 million USD by 2031.

The global gabapentin market has experienced significant growth, with sales surging to approximately $1.9816 billion in 2022. This upward trend is expected to continue, with a projected compound annual growth rate (CAGR) of 4.37% during the forecast period from 2023 to 2031, reaching an estimated $2.912 billion by 2031. Gabapentin, a widely used medication, has garnered considerable attention in the healthcare sector due to its effectiveness in treating various conditions. It belongs to the class of anticonvulsants and is primarily prescribed for the management of epilepsy and neuropathic pain. In addition to these uses, gabapentin has also been recognized for its utility in treating anxiety disorders, restless legs syndrome, and as an adjunct therapy for individuals suffering from opioid withdrawal. For application methods, please check the [PDF download] button or apply directly through the related links.

• 企業：Panorama Data Insights Ltd.
• 価格：Other

• others